NCT07636460

Brief Summary

The goal of this clinical trial is to find out if newly developed, culturally adapted educational videos-sent through a mobile messaging app-can help people with coronary heart disease do better in a home-based cardiac rehabilitation program in Malaysia. The main questions it aims to answer are:

  • Do the educational videos help participants improve their fitness?
  • Do the videos help participants better understand heart health and stick to a healthy lifestyle? Researchers will compare the educational videos to existing standard educational materials to see if the video-based education is more helpful for supporting rehabilitation at home. Participants will:
  • Take part in a 12-week home-based cardiac rehabilitation program
  • Receive either educational videos or standard education materials
  • Meet with the cardiac rehabilitation team every 4 weeks
  • Complete a treadmill exercise test, blood tests, and questionnaires before and after the program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2025

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 16, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 20, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

June 9, 2026

Completed
Last Updated

June 9, 2026

Status Verified

June 1, 2025

Enrollment Period

1.5 years

First QC Date

November 20, 2025

Last Update Submit

June 3, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Cardiovascular Fitness Measured using metabolic equivalents (METs) at Completion of Cardiac Rehabilitation Programme Phase 2

    Metabolic equivalents (METs) obtained through the Exercise Stress Test (EST), employing the modified Bruce protocol. Higher metabolic equivalents of task (METs) value indicate greater energy expenditure, higher physical intensity, and generally a better level of cardiorespiratory fitness. Conversely, a lower METs value indicates lower energy expenditure, lighter activity, and potentially a poorer functional capacity.

    Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

Secondary Outcomes (8)

  • Change from Baseline of Blood Glucose in Clinical Parameters of Cardiovascular Risk Factors at 12 Weeks of Cardiac Rehabilitation Programme Phase 2

    Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

  • Change from Baseline of Low-Density Lipoprotein Cholesterol in Clinical Parameters of Cardiovascular Risk Factors at 12 Weeks of Cardiac Rehabilitation Programme Phase 2

    Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

  • Change from Baseline of Body Fat Composition in Clinical Parameters of Cardiovascular Risk Factors at 12 Weeks of Cardiac Rehabilitation Programme Phase 2

    Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

  • Smoking Cessation in Behavioural Parameter Related to Lifestyle Changes at 12 Weeks of Cardiac Rehabilitation Programme Phase 2

    Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

  • Medication Adherence in Behavioural Parameter Related to Lifestyle Changes at 12 Weeks of Cardiac Rehabilitation Programme Phase 2

    Assessed at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

  • +3 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention group received an audiovisual version of Structured Patient Education Materials during Cardiac Rehabilitation Programme Phase 2, which were delivered via WhatsApp.

Other: Audiovisual Structured Patient Education Materials

Control

ACTIVE COMPARATOR

The control group received the standard visual-based educational materials currently used in UMMC's Cardiac Rehabilitation Program Phase 2, which were delivered via WhatsApp.

Other: Standard Educational Materials

Interventions

Bilingual (Malaysian and English language) Audiovisual Structured Patient Education Materials that are culturally adaptable on secondary prevention cardiac risk factors, self-care and exercise recommendations.

Intervention

Standard visual-based educational materials currently used in Cardiac Rehabilitation Programme Phase 2, Universiti Malaya Medical Centre

Control

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed as any form of ischaemic heart disease;
  • Classified as low to moderate risk based on American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) criteria through Exercise Stress Test (EST);
  • Cognitively intact and able to provide informed consent;
  • Literate and capable of utilising educational material;
  • Able to use and operate a smartphone with an exercise activity tracker (EAT).

You may not qualify if:

  • \- Classified as high risk according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Malaya Medical Centre

Kuala Lumpur, Kuala Lumpur, 50603, Malaysia

Location

MeSH Terms

Conditions

Myocardial InfarctionMyocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Anwar Suhaimi

    Universiti Malaya

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All of the parties are masked except the treating physician and non-participating investigator (a staff nurse), who maintained the allocation concealment list throughout the end of the trials.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2025

First Posted

June 9, 2026

Study Start

July 19, 2023

Primary Completion

January 8, 2025

Study Completion

January 16, 2025

Last Updated

June 9, 2026

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

IPD will not be shared with outside researchers, as the informed consent forms for this study did not include a provision for future sharing of individual participant data beyond the initial research team. Therefore, IPD cannot be shared to protect participant autonomy.

Locations